{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:54:20Z","timestamp":1787064860675,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ijrobp.2013.08.040","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T09:22:24Z","timestamp":1381396944000},"page":"1086-1093","source":"Crossref","is-referenced-by-count":49,"title":["High-Dose and Extended-Field Intensity Modulated Radiation Therapy for Early-Stage NK\/T-Cell Lymphoma of\u00a0Waldeyer's Ring: Dosimetric Analysis and Clinical Outcome"],"prefix":"10.1016","volume":"87","author":[{"given":"Xi-Wen","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Rong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2013.08.040_bib1","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib2","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/annonc\/mdn147","article-title":"Clinical heterogeneity of extranodal NK\/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group","volume":"19","author":"Kim","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0609.2012.01796.x","article-title":"Clinical features and prognostic model for extranasal NK\/T-cell lymphoma","volume":"89","author":"Jo","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib6","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-08-2914","article-title":"Variable clinical presentations of nasal and Waldeyer ring natural killer\/T-cell lymphoma","volume":"15","author":"Li","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","article-title":"Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality","volume":"54","author":"Cheung","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<449::AID-CNCR13>3.0.CO;2-W","article-title":"Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy","volume":"83","author":"Li","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib9","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1182\/blood-2008-05-160176","article-title":"Clinical features and treatment outcome of nasal-type NK\/T-cell lymphoma of Waldeyer ring","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2007.05.073","article-title":"Early or up-front radiotherapy improved survival of localized extranodal NK\/T-cell lymphoma, nasal-type in the upper aerodigestive tract","volume":"70","author":"Huang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdh143","article-title":"Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)\/T-cell lymphoma: a single institute survey in Taiwan","volume":"15","author":"You","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib12","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.ijrobp.2010.10.040","article-title":"Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK\/T-cell lymphoma","volume":"82","author":"Li","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib13","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2012-06-435024","article-title":"Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK\/T-cell lymphoma patients receiving primary radiotherapy","volume":"120","author":"Wang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib14","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.ijrobp.2004.05.022","article-title":"Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience","volume":"60","author":"Kam","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijrobp.2010.10.041","article-title":"Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience","volume":"82","author":"Setton","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s12094-012-0864-5","article-title":"Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma","volume":"14","author":"Kuang","year":"2012","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2011.02.039","article-title":"Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK\/T-cell lymphoma","volume":"82","author":"Wang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0167-8140(01)00428-5","article-title":"Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck","volume":"61","author":"Kim","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.2007.00876.x","article-title":"Prognostic factors for classifying extranodal NK\/T cell lymphoma, nasal type, as lymphoid neoplasia","volume":"79","author":"Na","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib21","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues","first-page":"285","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2008"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib22","first-page":"1860","article-title":"Report of the committee on\u00a0Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"issue":"Suppl 3","key":"10.1016\/j.ijrobp.2013.08.040_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3171\/jns.2000.93.supplement_3.0219","article-title":"A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note","volume":"93","author":"Paddick","year":"2000","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib26","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-8140(01)00449-2","article-title":"Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques","volume":"61","author":"Chao","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib28","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","article-title":"Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients","volume":"25","author":"Kam","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib29","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.ijrobp.2007.08.028","article-title":"A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma","volume":"69","author":"Poon","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.radonc.2011.11.017","article-title":"Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT","volume":"104","author":"Lu","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.meddos.2012.05.002","article-title":"Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for 18F-FDG-PET-guided dose escalation in oropharyngeal cancer: a planning study","volume":"38","author":"Teoh","year":"2013","journal-title":"Med Dosim"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib32","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2004.12.076","article-title":"Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy","volume":"62","author":"Blanco","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1748-717X-8-20","article-title":"Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysis","volume":"8","author":"Saleh-Ebrahimi","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0360-3016(03)00405-X","article-title":"Intensity-modulated radiation therapy\u00a0for head-and-neck cancer: the UCSF experience focusing on target\u00a0volume delineation","volume":"57","author":"Lee","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2013.08.040_bib35","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer (NK)\/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group","volume":"120","author":"Kwong","year":"2012","journal-title":"Blood"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301613030757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301613030757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T11:36:54Z","timestamp":1564486614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301613030757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0360301613030757"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2013.08.040","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}